Who invested in Neuralink?
Neuralink's investors include Founders Fund, Valor Equity Partners, Vy Capital, Sequoia Capital and Lightspeed Venture Partners, and 16 more on record.

United States · Venture startup
4 rounds we have observed, with the 21 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 6 months agoValuation: $9.7B, Mar 2026
Follow Neuralink and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$882Mraised across 4 rounds since 2017, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Also list them on their own siteHypersphere Capital
Reported by Crunchbase News and 3 othersSEC filing: $649M sold, first sale May 2025
Reported by Firms' own news pagesSEC filing: $206M sold, first sale Jul 2021
No investor was named in the report.
Reported by TechCrunchSEC filing: $27M sold, first sale Aug 2017
Neuralink filed 5 raises, $1.2B in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Neuralink's investors include Founders Fund, Valor Equity Partners, Vy Capital, Sequoia Capital and Lightspeed Venture Partners, and 16 more on record.
Neuralink has raised $882M across 4 rounds since 2017. One round did not disclose an amount, so the total is a floor.
Neuralink's most recent round was a Venture in May 2026.
Neuralink's largest round on record is $650M (Series E), in Jun 2025, led by GrowthCap Ventures.
Neuralink's first round on record, in Jul 2021, was backed by Vy Capital, Founders Fund and Google Ventures and 9 others.
Neuralink's latest named round is a Venture, in May 2026.
Neuralink is based in the United States.
Vy Capital led the Series C in 2021; GrowthCap Ventures led the Series E in 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.